Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is approved for AMA PRA Category 1 Credit™.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.
February 9, 2019
InterContinental New York Times Square
300 W 44th St.
New York, NY 10036
PER’s 15th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a 1-day educational conference, revolutionizing the presentation of emerging therapies and evolving standards of care in the management of patients with melanoma and other cutaneous malignancies.
Led by world-renowned experts Jeffrey S. Weber, MD, PhD, and Omid Hamid, MD, this international symposium, now in its 15th year, will provide physicians with the tools they need to personalize care for every patient they treat. Sessions will include presentations on advances in immunotherapy, the latest on targeted therapies, the benefits of regional therapy, how to use predictive and prognostic modeling, how to manage treatment-related adverse events associated with emerging strategies, and more! This year’s symposium will once again feature the dynamic and interactive Medical Crossfire® format, where experts will engage in a rigorous debate to answer your questions, and reach consensus on ongoing paradigm shifts. This fast-paced and interactive forum will once again prove highly practical to physicians who treat patients with skin cancer and provide them with unmatched access to the leading experts. Join us in New York, and together, we’ll meet the challenges currently facing the field!
What you will learn at the International Symposium on Melanoma!
This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate.
At the conclusion of this symposium, you should be better prepared to: